Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe

Background: Creating new therapies often involves drug companies paying healthcare professionals and institutions for research and development (R&D) activities, including clinical trials. However, industry sponsorship can create conflicts of interest (COIs). We analysed approaches to drug compan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozieranski, Piotr, Martinon, Luc, Jachiet, Pierre-Alain, Mulinari, Shai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105170/
https://www.ncbi.nlm.nih.gov/pubmed/35297231
http://dx.doi.org/10.34172/ijhpm.2022.6575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105170/
https://www.ncbi.nlm.nih.gov/pubmed/35297231
http://dx.doi.org/10.34172/ijhpm.2022.6575

Ejemplares similares